SP-1-39

N/A

Report date: 2025/01/26 18:06:36
NME

Base Information

Drug NameSP-1-39
Drug Alias NameTubulin inhibitor (University of Tennessee Health Science Center)SP-1-39
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Tennessee Health Science Center
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Tennessee Health Science Center
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A